{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:30:03Z","timestamp":1760866203973,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002649","name":"Yeungnam University","doi-asserted-by":"publisher","award":["217A580029"],"award-info":[{"award-number":["217A580029"]}],"id":[{"id":"10.13039\/501100002649","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:sup>18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) shows great potential for diagnosis and assessing therapeutic response of tuberculous spondylitis. Tuberculous spondylitis required long-term anti-tuberculosis (TB) medication therapy, and the optimal duration of therapy is controversial. There is still no clear way to tell when the anti-TB therapy can safely be discontinued.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Three patients with tuberculous spondylitis were evaluated for therapeutic response using 18F-FDG PET\/magnetic resonance imaging (MRI). Clinical and hematological improvements were achieved after about 12\u2009months of anti-TB medication therapy, and we considered whether to discontinue the therapy. There was no relapse during one year of follow-up after discontinuation of 12\u2009months anti-TB medication based on the low maximum standardized uptake value (SUV<jats:sub>max<\/jats:sub>) of 1.83 in one patient. However, the other two patients continued further anti-TB medication therapy based on the high SUVmax of 4.14 and 7.02, which were suspected to indicate active residual lesions in the abscess or granulation tissues. Continuous TB was confirmed by the bacterial and histological examinations.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>18F-FDG PET\/MRI has metabolic and anatomical advantages for assessing therapeutic response in TB spondylitis, and can be considered as a helpful independent and alternative method for determining the appropriate time to discontinue anti-TB medication.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4469-2","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T12:47:42Z","timestamp":1571143662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Simultaneous 18F-FDG PET\/MRI in tuberculous spondylitis: an independent method for assessing therapeutic response - case series"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-2724","authenticated-orcid":false,"given":"Ikchan","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunjung","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"issue":"9","key":"4469_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49(9):1350\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4469_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00247-004-1223-7","volume":"34","author":"HE Teo","year":"2004","unstructured":"Teo HE, Peh WC. Skeletal tuberculosis in children. Pediatr Radiol. 2004;34(11):853\u201360.","journal-title":"Pediatr Radiol"},{"key":"4469_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2342-13-37","volume":"13","author":"Y Kimizuka","year":"2013","unstructured":"Kimizuka Y, Ishii M, Murakami K, Ishioka K, Yagi K, Ishii K, Watanabe K, Soejima K, Betsuyaku T, Hasegawa N. A case of skeletal tuberculosis and psoas abscess: disease activity evaluated using (18) F-fluorodeoxyglucose positron emission tomography-computed tomography. BMC Med Imaging. 2013;13:37.","journal-title":"BMC Med Imaging"},{"issue":"4","key":"4469_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0736-4679(95)80006-9","volume":"13","author":"RA Harrigan","year":"1995","unstructured":"Harrigan RA, Kauffman FH, Love MB. Tuberculous psoas abscess. J Emerg Med. 1995;13(4):493\u20138.","journal-title":"J Emerg Med"},{"issue":"3","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/RCT.0b013e318219f810","volume":"35","author":"G Treglia","year":"2011","unstructured":"Treglia G, Taralli S, Calcagni ML, Maggi F, Giordano A, Bonomo L. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography\/computed tomography in evaluating patients with mycobacteriosis? A systematic review. J Comput Assist Tomogr. 2011;35(3):387\u201393.","journal-title":"J Comput Assist Tomogr"},{"issue":"9","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3109\/02841851.2010.504744","volume":"51","author":"G Tian","year":"2010","unstructured":"Tian G, Xiao Y, Chen B, Xia J, Guan H, Deng Q. FDG PET\/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis. Acta Radiol. 2010;51(9):1002\u20136.","journal-title":"Acta Radiol"},{"key":"4469_CR7","unstructured":". In: Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. edn. Geneva; 2014."},{"issue":"1","key":"4469_CR8","first-page":"147","volume":"109","author":"LG Wayne","year":"1974","unstructured":"Wayne LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 1974;109(1):147\u201351.","journal-title":"Am Rev Respir Dis"},{"issue":"24","key":"4469_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1056\/NEJM199406163302402","volume":"330","author":"PM Small","year":"1994","unstructured":"Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994;330(24):1703\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"4469_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(09)70042-8","volume":"9","author":"RS Wallis","year":"2009","unstructured":"Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis. 2009;9(3):162\u201372.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4469_CR11","first-page":"103","volume":"57","author":"G Walzl","year":"2008","unstructured":"Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM. Biomarkers for TB treatment response: challenges and future strategies. J Inf Secur. 2008;57(2):103\u20139.","journal-title":"J Inf Secur"},{"key":"4469_CR12","doi-asserted-by":"publisher","first-page":"k3793","DOI":"10.1136\/bmj.k3793","volume":"363","author":"E Kedhi","year":"2018","unstructured":"Kedhi E, Fabris E, van der Ent M, Buszman P, von Birgelen C, Roolvink V, Zurakowski A, Schotborgh CE, Hoorntje JCA, Eek CH, et al. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. BMJ. 2018;363:k3793.","journal-title":"BMJ"},{"issue":"2","key":"4469_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semarthrit.2006.04.007","volume":"36","author":"L Le Page","year":"2006","unstructured":"Le Page L, Feydy A, Rillardon L, Dufour V, Le Henanff A, Tubach F, Belmatoug N, Zarrouk V, Guigui P, Fantin B. Spinal tuberculosis: a longitudinal study with clinical, laboratory, and imaging outcomes. Semin Arthritis Rheum. 2006;36(2):124\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4469_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/amhsr.amhsr_188_15","volume":"6","author":"R Singh","year":"2016","unstructured":"Singh R, Magu NK, Rohilla RK. Clinicoradiologic profile of involvement and healing in tuberculosis of the spine. Ann Med Health Sci Res. 2016;6(5):311\u201327.","journal-title":"Ann Med Health Sci Res"},{"issue":"2","key":"4469_CR15","first-page":"132","volume":"48","author":"AK Jain","year":"2000","unstructured":"Jain AK, Jena A, Dhammi IK. Correlation of clinical course with magnetic resonance imaging in tuberculous myelopathy. Neurol India. 2000;48(2):132\u20139.","journal-title":"Neurol India"},{"issue":"3","key":"4469_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.semnuclmed.2007.01.001","volume":"37","author":"U Metser","year":"2007","unstructured":"Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography\/computed tomography (PET\/CT): accumulated data from four years of experience with PET\/CT. Semin Nucl Med. 2007;37(3):206\u201322.","journal-title":"Semin Nucl Med"},{"issue":"4","key":"4469_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s005340200065","volume":"9","author":"N Sanabe","year":"2002","unstructured":"Sanabe N, Ikematsu Y, Nishiwaki Y, Kida H, Murohisa G, Ozawa T, Hasegawa S, Okawada T, Toritsuka T, Waki S. Pancreatic tuberculosis. J Hepato-Biliary-Pancreat Surg. 2002;9(4):515\u20138.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"issue":"5","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.tube.2007.05.013","volume":"87","author":"A Hofmeyr","year":"2007","unstructured":"Hofmeyr A, Lau WF, Slavin MA. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis (Edinb). 2007;87(5):459\u201363.","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RLU.0b013e31815c5128","volume":"33","author":"IN Park","year":"2008","unstructured":"Park IN, Ryu JS, Shim TS. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med. 2008;33(1):1\u20133.","journal-title":"Clin Nucl Med"},{"key":"4469_CR20","doi-asserted-by":"crossref","unstructured":"Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine. Int Orthop 1999, 23(2):73\u201381.","DOI":"10.1007\/s002640050311"},{"issue":"963","key":"4469_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/pgmj.2005.032862","volume":"82","author":"L Cormican","year":"2006","unstructured":"Cormican L, Hammal R, Messenger J, Milburn HJ. Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J. 2006;82(963):46\u201351.","journal-title":"Postgrad Med J"},{"issue":"2","key":"4469_CR22","first-page":"241","volume":"14","author":"AJ Nunn","year":"2010","unstructured":"Nunn AJ, Phillips PP, Mitchison DA. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010;14(2):241\u20132.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4469-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T23:08:19Z","timestamp":1602630499000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4469-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Voluntary written informed consent was obtained prior to the study from the patients under approval of the Institutional Review Board, Yeungnam University Hospital (No. 2017\u201307-006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient or patient\u2019s family for publication of this case series and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"845"}}